Maria A. Rocca

Research interests

Publications

• Diagnosis of multiple sclerosis: 2024 revisions of the McDonald criteria

  The Lancet Neurology · 2025 · https://doi.org/10.1016/s1474-4422(25)00270-4

• 2021 MAGNIMS–CMSC–NAIMS consensus recommendations on the use of MRI in patients with multiple sclerosis

  The Lancet Neurology · 2021 · https://doi.org/10.1016/s1474-4422(21)00095-8

• Glymphatic system impairment in multiple sclerosis: relation with brain damage and disability

  Brain · 2021 · https://doi.org/10.1093/brain/awab454

• MAGNIMS consensus recommendations on the use of brain and spinal cord atrophy measures in clinical practice

  Nature Reviews Neurology · 2020 · https://doi.org/10.1038/s41582-020-0314-x

• Assessment of lesions on magnetic resonance imaging in multiple sclerosis: practical guidelines

  Brain · 2019 · https://doi.org/10.1093/brain/awz144

• Association between pathological and MRI findings in multiple sclerosis

  The Lancet Neurology · 2019 · https://doi.org/10.1016/s1474-4422(18)30451-4

• Multiple sclerosis

  Nature Reviews Disease Primers · 2018 · https://doi.org/10.1038/s41572-018-0041-4

• Cognition in multiple sclerosis

  Neurology · 2018 · https://doi.org/10.1212/wnl.0000000000004977

• Deep gray matter volume loss drives disability worsening in multiple sclerosis

  Annals of Neurology · 2018 · https://doi.org/10.1002/ana.25145

• Progression of regional grey matter atrophy in multiple sclerosis

  Brain · 2018 · https://doi.org/10.1093/brain/awy088

• MRI criteria for the diagnosis of multiple sclerosis: MAGNIMS consensus guidelines

  The Lancet Neurology · 2016 · https://doi.org/10.1016/s1474-4422(15)00393-2

• MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis—clinical implementation in the diagnostic process

  Nature Reviews Neurology · 2015 · https://doi.org/10.1038/nrneurol.2015.106

• Clinical and imaging assessment of cognitive dysfunction in multiple sclerosis

  The Lancet Neurology · 2015 · https://doi.org/10.1016/s1474-4422(14)70250-9

• Placebo-Controlled Trial of Oral Laquinimod for Multiple Sclerosis

  New England Journal of Medicine · 2012 · https://doi.org/10.1056/nejmoa1104318

• A randomised, double blind, placebo controlled trial with vitamin D 3 as an add on treatment to interferon β-1b in patients with multiple sclerosis

  Journal of Neurology Neurosurgery & Psychiatry · 2012 · https://doi.org/10.1136/jnnp-2011-301876

• Association between pathological and MRI findings in multiple sclerosis

  The Lancet Neurology · 2012 · https://doi.org/10.1016/s1474-4422(12)70003-0

• MR Imaging of Multiple Sclerosis

  Radiology · 2011 · https://doi.org/10.1148/radiol.11101362

• Rapid semi-automatic segmentation of the spinal cord from magnetic resonance images: Application in multiple sclerosis

  NeuroImage · 2010 · https://doi.org/10.1016/j.neuroimage.2009.12.121

• Default-mode network dysfunction and cognitive impairment in progressive MS

  Neurology · 2010 · https://doi.org/10.1212/wnl.0b013e3181d9ed91

• MRI in multiple sclerosis: current status and future prospects

  The Lancet Neurology · 2008 · https://doi.org/10.1016/s1474-4422(08)70137-6

• Brain Gray Matter Changes in Migraine Patients With T2-Visible Lesions

  Stroke · 2006 · https://doi.org/10.1161/01.str.0000226589.00599.4d

• Functional Magnetic Resonance Imaging Correlates of Fatigue in Multiple Sclerosis

  NeuroImage · 2002 · https://doi.org/10.1006/nimg.2001.1011

• Relation between MR abnormalities and patterns of cognitive impairment in multiple sclerosis

  Neurology · 1998 · https://doi.org/10.1212/wnl.50.6.1601

• Magnetization transfer changes in the normal appering white matter precede the appearance of enhancing lesions in patients with multiple sclerosis

  Annals of Neurology · 1998 · https://doi.org/10.1002/ana.410430616

Current projects

No projects listed.